Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000471751 | SCV000558310 | likely benign | Ataxia-telangiectasia syndrome | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001182719 | SCV001348270 | likely benign | Hereditary cancer-predisposing syndrome | 2017-03-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001653845 | SCV001870119 | benign | not provided | 2015-06-02 | criteria provided, single submitter | clinical testing | |
National Health Laboratory Service, |
RCV002225627 | SCV002505331 | likely benign | Hereditary breast ovarian cancer syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004591338 | SCV005084987 | likely benign | Familial cancer of breast | 2024-05-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |
Prevention |
RCV004551549 | SCV004709915 | likely benign | ATM-related disorder | 2022-08-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |